Sarah L Allinson

7PUBLICATIONS
29CO-AUTHORS
PharmacogenomicsGlassSupramolecular chemistryGene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 27, 2026
Correction: Pauzaite et al. Dbf4-Cdc7 (DDK) Inhibitor PHA-767491 Displays Potent Anti-Proliferative Effects via Crosstalk with the CDK2-RB-E2F Pathway. Biomedicines 2022, 10, 2012.

|Jul 27, 2024
Brown Algae as a Valuable Substrate for the Cost-Effective Production of Poly-γ-Glutamic Acid for Applications in Cream Formulations.

Mattia Parati, Catherine Philip, Sarah L Allinson

|Jun 07, 2023
A practical synthesis of 1,3-disubstituted cubane derivatives.

Nahin Kazi, Marine C Aublette, Sarah L Allinson

|Nov 22, 2022
Genetically engineered multicistronic allele of Pmel yielding highly specific CreERT2-mediated recombination in the melanocyte lineage.

Emma L Wilkinson, Louise C Brennan, Olivia J Harrison

|Aug 26, 2022
Dbf4-Cdc7 (DDK) Inhibitor PHA-767491 Displays Potent Anti-Proliferative Effects via Crosstalk with the CDK2-RB-E2F Pathway.

Tekle Pauzaite, James Tollitt, Betul Sopaci

|Jun 14, 2022
Fingerprinting of skin cells by live cell Raman spectroscopy reveals melanoma cell heterogeneity and cell-type-specific responses to UVR.

Emma L Wilkinson, Lorna Ashton, Jemma G Kerns

Pageof 2

Frequent Collaborators

2 joint publications

Jemma G Kerns

2 joint publications

Lorna Ashton

2 joint publications

Emma L Wilkinson

2 joint publications

Richard L Mort